380 related articles for article (PubMed ID: 25501271)
21. Meta-analysis of CT and MRI for differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma.
Ha J; Choi SH; Byun JH; Kim KW; Kim SY; Kim JH; Kim HJ
Eur Radiol; 2021 May; 31(5):3427-3438. PubMed ID: 33146798
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of focal-type autoimmune pancreatitis from pancreatic carcinoma: assessment by multiphase contrast-enhanced CT.
Furuhashi N; Suzuki K; Sakurai Y; Ikeda M; Kawai Y; Naganawa S
Eur Radiol; 2015 May; 25(5):1366-74. PubMed ID: 25433412
[TBL] [Abstract][Full Text] [Related]
23. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
[TBL] [Abstract][Full Text] [Related]
24. Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings.
Muhi A; Ichikawa T; Motosugi U; Sou H; Sano K; Tsukamoto T; Fatima Z; Araki T
J Magn Reson Imaging; 2012 Apr; 35(4):827-36. PubMed ID: 22069025
[TBL] [Abstract][Full Text] [Related]
25. Difficulty in diagnosing autoimmune pancreatitis by imaging findings.
Nakazawa T; Ohara H; Sano H; Ando T; Imai H; Takada H; Hayashi K; Kitajima Y; Joh T
Gastrointest Endosc; 2007 Jan; 65(1):99-108. PubMed ID: 17185087
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma.
Hur BY; Lee JM; Lee JE; Park JY; Kim SJ; Joo I; Shin CI; Baek JH; Kim JH; Han JK; Choi BI
J Magn Reson Imaging; 2012 Jul; 36(1):188-97. PubMed ID: 22371378
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune pancreatitis: imaging findings on contrast-enhanced MR, MRCP and dynamic secretin-enhanced MRCP.
Carbognin G; Girardi V; Biasiutti C; Camera L; Manfredi R; Frulloni L; Hermans JJ; Mucelli RP
Radiol Med; 2009 Dec; 114(8):1214-31. PubMed ID: 19789959
[TBL] [Abstract][Full Text] [Related]
28. The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma.
Pak LM; Schattner MA; Balachandran V; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Allen PJ
HPB (Oxford); 2018 Feb; 20(2):182-187. PubMed ID: 29033025
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic tumor in type 1 autoimmune pancreatitis: a diagnostic challenge.
Xiang P; Zhang X; Wang C; Lang Y; Xu L; Huang L; Shen J; Feng ST
BMC Cancer; 2019 Aug; 19(1):814. PubMed ID: 31419961
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
[TBL] [Abstract][Full Text] [Related]
31. Differential Diagnosis of Autoimmune Pancreatitis From Pancreatic Cancer by Analysis of Serum Gelatinase Levels.
Felix K; Dobiasch S; Gaida MM; Schneider K; Werner J; Martens E; Vandooren J; Opdenakker G
Pancreas; 2016 Aug; 45(7):1048-55. PubMed ID: 26692441
[TBL] [Abstract][Full Text] [Related]
32. Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer.
Sun GF; Zuo CJ; Shao CW; Wang JH; Zhang J
World J Gastroenterol; 2013 Jun; 19(23):3634-41. PubMed ID: 23801866
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of pancreatic head ductal adenocarcinoma from inflammatory pancreatic pseudomass by MR cholangio-pancreatography: utility of the duct-interrupted, corona, and attraction signs.
Beker K; Lee KS; Tsai LL; Hegazi T; Garces-Descovich A; Brook A; Mortele KJ
Abdom Radiol (NY); 2019 Dec; 44(12):4048-4056. PubMed ID: 31352623
[TBL] [Abstract][Full Text] [Related]
34. The differentiation of autoimmune pancreatitis and pancreatic cancer using imaging findings.
Shin JU; Lee JK; Kim KM; Lee KH; Lee KT; Kim YK; Lim JH; Jang KT
Hepatogastroenterology; 2013; 60(125):1174-81. PubMed ID: 24298613
[TBL] [Abstract][Full Text] [Related]
35. Diffuse Pancreatic Cancer Mimicking Autoimmune Pancreatitis.
Miyoshi H; Kano M; Kobayashi S; Ito T; Masuda M; Mitsuyama T; Nakayama S; Ikeura T; Shimatani M; Uchida K; Takaoka M; Okazaki K
Intern Med; 2019 Sep; 58(17):2523-2527. PubMed ID: 31178502
[TBL] [Abstract][Full Text] [Related]
36. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma.
Wakabayashi T; Kawaura Y; Satomura Y; Watanabe H; Motoo Y; Okai T; Sawabu N
Am J Gastroenterol; 2003 Dec; 98(12):2679-87. PubMed ID: 14687817
[TBL] [Abstract][Full Text] [Related]
37. Morphologic patterns of autoimmune pancreatitis in CT and MRI.
Rehnitz C; Klauss M; Singer R; Ehehalt R; Werner J; Büchler MW; Kauczor HU; Grenacher L
Pancreatology; 2011; 11(2):240-51. PubMed ID: 21625195
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping.
Kim M; Jang KM; Kim JH; Jeong WK; Kim SH; Kang TW; Kim YK; Cha DI; Kim K
Eur Radiol; 2017 Apr; 27(4):1722-1732. PubMed ID: 27510628
[TBL] [Abstract][Full Text] [Related]
39. The role of apparent diffusion coefficient value in the diagnosis of localized type 1 autoimmune pancreatitis: differentiation from pancreatic ductal adenocarcinoma and evaluation of response to steroids.
Sekito T; Ishii Y; Serikawa M; Tsuboi T; Kawamura R; Tsushima K; Nakamura S; Hirano T; Fukiage A; Mori T; Ikemoto J; Kiyoshita Y; Saeki S; Tamura Y; Miyamoto S; Chayama K
Abdom Radiol (NY); 2021 May; 46(5):2014-2024. PubMed ID: 33386451
[TBL] [Abstract][Full Text] [Related]
40. Clinical differences between mass-forming autoimmune pancreatitis and pancreatic cancer.
Naitoh I; Nakazawa T; Hayashi K; Okumura F; Miyabe K; Shimizu S; Kondo H; Yoshida M; Yamashita H; Ohara H; Joh T
Scand J Gastroenterol; 2012 May; 47(5):607-13. PubMed ID: 22416894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
